A process for preparing nanocapsules having a core-shell structure, comprising: (a) preparing an oil-in-water emulsion by emulsification of an oily phase that comprises a core material, in an aqueous phase, under high shear forces, wherein one or both of the oily phase, and the aqueous phase comprises a sol-gel precursor; (b) subjecting the emulsion obtained in (a) to a high pressure homogenization to obtain a nano-emulsion; and (c) applying conditions for hydrolyzing and polycondensing the sol-gel precursor to obtain nanocapsules having a metal oxide shell encapsulating the core material, said nanocapsules have a particle size distribution of: d10=10-80 nm, d50=30-200 nm, and d90=70-500 nm, in diameter. The invention also relate to nanocapsules having the above particle size distribution and to composition comprising the nanocapsules.

A method of treating hair more precisely including providing a hair treatment composition in a foam dispenser, dispensing the hair treatment composition directly onto the hair as a foam, leaving the foam on the hair, and rinsing the foam from the hair. The foam dispenser includes a reservoir for holding the hair treatment composition, an extended nozzle connected to the reservoir, and one or more nozzle orifices. The one or more nozzle orifices has a total orifice area of from about 5 mm.sup.2 to about 80 mm.sup.2. The extended nozzle has a protrusion length of from about 20 mm to about 125 mm. The foam has a specific volume of from about 4 ml/g to about 20 ml/g.

The present invention relates to the use as perfuming ingredient of a compound of formula ##STR00001##
in the form of any one of its stereoisomers or a mixture thereof, and wherein one dotted line represents a carbon-carbon single bond and the other a carbon-carbon double bond; and R represents a hydrogen atom or a C.sub.1-4 alkyl or alkenyl group; as well as to the perfuming composition and the consumer products containing said compound.

The present invention relates to a method for preventing or treating disease in a mammal, particularly a human, by maintaining a fluoride free diet. Such diseases include autism, cancer, Alzheimer's disease, multiple sclerosis, calcification of the pineal gland, diabetes, depression, schizophrenia, psychotic diseases, muscular dystrophy, and others.

The present invention relates to a method for preventing or treating disease in a mammal, particularly a human, by maintaining a fluoride free diet. Such diseases include autism, cancer, Alzheimer's disease, multiple sclerosis, calcification of the pineal gland, diabetes, depression, schizophrenia, psychotic diseases, muscular dystrophy, and others.

A system is provided that includes a mobile user device executes an application that receives a selection of a target color of lipstick from a user, and determines and transmit a recipe for generating the target color of the lipstick that is based on a combination of a plurality of separate lipstick ingredients. The system includes a dispensing device configured to receive the transmitted recipe from the mobile user device and dispense each of the plurality of separate lipstick ingredients onto a common dispensing surface such that when the dispensed amounts of each of the plurality of separate lipstick ingredients is blended on the dispensing surface, the target color of the lipstick is achieved. The mobile user device is configured to present at least one candidate color of lipstick to the user that is based on at least a user profile of the user of the smartphone.

A system is provided that includes a mobile user device that executes an application that determines a skintone of a user, and determines and transmits a recipe for generating a target foundation that is based on a combination of a plurality of separate foundation ingredients that are associated with the skintone of the user. The system includes a dispensing device configured to receive the transmitted recipe from the mobile user device and dispense each of the plurality of separate foundation ingredients onto a common dispensing surface such that when the dispensed amounts of each of the plurality of separate foundation ingredients is blended on the dispensing surface, the target foundation is achieved. The mobile user device is configured to determine a skintone of the user based on features in a detected face of the user in a self-taken image of the user that is captured by a camera of the mobile user device.

The disclosure relates to antimicrobial compositions and their methods of use and manufacture. In particular, the antimicrobial compositions described herein comprise an antimicrobial active, a primary foaming agent, and an L-amino acid to provide rapid antimicrobial efficacy. In a preferred embodiment, the antimicrobial compositions are dermal cleansers. In a most preferred embodiment, the antimicrobial compositions comprise a foam structure enhancing agent.

Fragrance control is provided by articles of manufacture including various solid state fragrancing objects, methods of using such objects, and systems that employ one or more such objects. The fragrancing object can be easy to manufacture, long lasting, provide fragrance that is consistently released over time, provide an indication to the user that the object needs to be replaced, and can hold a desired ratio of fragrance. The solid state fragrancing object can be coupled to an air vent to inconspicuously provide fragrance to a user in an environment, such as the interior of a vehicle.

Methods for delivery of a biologic agent to the dermis or superficial muscles by topical application of the agent are provided. The methods comprise, in one embodiment, treating or conditioning a skin area to disrupt the stratum corneum in the skin area to define a treated skin area and applying a formulation comprising a biologic agent to the treated skin area.